OncUpdates· @OncUpdates · X·· 15 小时前评分70
正文 · 原文
🤩 @OncBrothers highlighting 🔑 studies presented on Day 1 of #ESMO26
#BreastCancer
1. #NATALEE
2. #HorizonBreast06
3. #TALENT
#GIOnc
4. #RASolute302
5. #HerizonGEA01
#GUOnc
6. #KN866
7. #PEACE1
#OncTwitter #MedTwitter #bcsm #gism #gucsm @myESMO #MedX #MedEd #Oncology
60 浏览 · 2 赞 · 1 转发 · 0 回复
会议摘要
LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgDay 1 #ESMO26 highlights Breast Ca 1. #NATALEE (update): Ribo Adj HR+ 2. #HorizonBreast06: ADCs in mBC 3. #TALENT: NeoAdj TDXd HR+ GI 4. #RASolute302: Panc Ca 5. #HerizonGEA01: GEJ/Gastric GU 6. #KN866: NeoAdj Pembro MIBC 7. #PEACE1: Abi in mHSPC #OncTwitter @myESMO 1/8在 X 查看被引用的帖子
来源：OncUpdates · x.com